Study of Hypertrophic Cardiomyopathy Under Stress Conditions. Concordance Between Two Complementary Tests: Stress MRI and Exercice Stress Echocardiography
NCT02500420 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2015-09-03
Summary
Hypertrophic cardiomyopathy (HCM) is a primitive myocardic disease and the first of genetic cardiac diseases. The definition of HCM is an increase of the myocardial thickness of the left ventricle (LV) wall without any other causes of hypertrophy. It's characterized by an important heterogeneity of prognosis and clinical expression going from a asymptomatic state until the devastating sudden death occurring in a young person.The diagnosis of HCM is definite by a myocardial thickness greater or equal to 15mm (or 13mm if there is a familial history).This hypertrophy is often accompanied by other abnormalities detected by echocardiography: dynamic left ventricular outflow obstruction at rest or stress, mitral regurgitation …Now, the current challenge is to determine the prognosis factors of the disease that could help to identify the patients with high risk of sudden death. Some prognosis factors are knowed and used in the calculation of a new risk score. This risk score allows to estimate the risk of sudden death at 5 years and propose depending on the result, the implantation of a defibrillator for primary prevention.The physiopathological mechanism of HCM is very complex and still misunderstood. Myocardial fibrosis could be a major mechanism of the disease evolution. Indeed, fibrosis is responsible of scar areas where ventricular tachycardia may develop. Moreover, if the fibrosis is very extensive, it can be the responsible of a systolic or diastolic dysfunction of the left ventricle leading to heart failure.Myocardial ischemia caused by a microvascular dysfunction is now recognized as an important mechanism of the disease evolution. Acute ischemic events could be a trigger of malignant arrhythmia whereas chronic ischemia leads to fibrosis.Left ventricle function is long time preserved in HCM. Segmentary hypokinesia corresponding to extensive fibrosis appears at a very advanced stage of the disease. Exercice stress echocardiography permits to detect myocardial ischemia caused by microvascular dysfunction in the HCM before the fibrosis apparition. Moreover the investigators suggest to study the deformation parameters by speckle tracking or 2D strain witness of a contractile LV dysfunction before the apparition of segmentary hypokinesia.Magnetic resonance imaging (MRI) is now recognized as the more sensible technique to identify focal myocardial fibrosis resulting in areas of late gadolinium enhancement (LGE). LGE is frequent in HCM and his extension is correlated with the severity of the hypertrophy and the risk of sudden death. Myocardial ischemia is detected by hypoperfused defects in the perfusion sequences and as LGE, is correlated with the degree of hypertrophy. Some studies using stress MRI with vasodilatator agent show inductible hypoperfused areas correlated to the degree of hypertrophy. T1 mapping is a new hopeful sequence of MRI permitting to detect the diffuse and early myocardial fibrosis. Some studies show that T1 mapping values are reduced in the areas of LGE in HCM but also in areas without LGE which reflects the presence of new fibrosis.The objective of study is to compare these two imagery techniques in order to detect ischemia and fibrosis. These techniques are usually used in the diagnosis or the monitoring of the disease. The investigators propose to realize an exercise stress echocardiography to study: the segmentary kinetic of the left ventricle and the 2D strain and a stress MRI to study the LGE, the stress perfusion and the T1 mapping.Actually the investigators consider that LGE is a risk factor of the disease (although not yet involved in the calculation of the risk of sudden death) and need to be study in each MRI realized for HCM. From the same way, the investigators suggest to follow patients to determine if the abnormalities detected by these two techniques and particularly 2D strain abnormalities, stress myocardial ischemia and T1 mapping abnormalities are prognosis factors of the disease and appear more precociously than LGE.
Conditions
Interventions
- OTHER
-
Diagnosis examens
* Cardiac MRI: is usually recommended in the diagnosis or in the follow-up of the disease. The MRI will respect the standard protocol: cineMRI sequences, perfusion sequences, LGE sequences at 10 minutes after gadolinium injection. The investigators will realize some additional sequences: T1 mapping before and after gadolinium injection to study the diffuse fibrosis and stress perfusion sequences after injection of a vasodilatator (Persantine°). * Exercice stress echocardiography: is realized almost systematically in all the diagnosis of HCM and it's very informative. The investigators will research left ventricular dysfunction: in particular segmentary hypokinesia and anomalies of deformation parameters (2D Strain) and the development of a dynamic left ventricular outflow obstruction or a mitral regurgitation at exercice.
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2015-08-31
- Completion
- 2017-08-31
Countries
- France
Study Locations
More Related Trials
-
Family Studies of Inherited Heart Disease
NCT00001225 ·Status: COMPLETED
-
Acute Myocardial Dysfunction and Chest Trauma - The Strainy Trauma Study
NCT04748003 ·Status: COMPLETED
-
Observational Study for Patients With Hypertrophic Cardiomyopathy
NCT04851652 ·Status: RECRUITING
-
Role of Stress CMR in Predicting Adverse Clinical Events in Patients With Known or Suspected IHD
NCT01821924 ·Status: COMPLETED
-
Outcome of Different Pathogenic Mutations in Hypertrophic Cardiomyopathy
NCT03726424 ·Status: UNKNOWN
-
Differentiation HHD From HCM (EARLY-MYO-HHD)
NCT03271385 ·Status: COMPLETED
-
Myocardial Ischemia in Non-obstructive Coronary Artery Disease
NCT01853527 ·Status: COMPLETED
-
Effect of Aterial Stiffness on Myocardial Work in Patients With Hypertension
NCT04573257 ·Status: UNKNOWN
-
Exercise Echocardiography on LV Mechanics in Patients With CAD: a Speckle-tracking Echocardiography
NCT04824001 ·Status: UNKNOWN
-
Analysis of Heart Muscle Function Following Exercise in Patients With Heart Disease
NCT00001528 ·Status: COMPLETED
-
CVD Risk Profile in Children With HCM
NCT05510180 ·Status: COMPLETED
-
Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease
NCT00001632 ·Status: COMPLETED
-
Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve
NCT03249272 ·Status: TERMINATED ·Phase: PHASE4
-
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
NCT00181259 ·Status: RECRUITING
-
Clinical, Morphological and Functional Aspects in Myocarditis.
NCT04217876 ·Status: COMPLETED
-
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
NCT01915615 ·Status: ACTIVE_NOT_RECRUITING
-
Stress Echo 2020 - The International Stress Echo Study
NCT03049995 ·Status: UNKNOWN
-
Study of Myocardial Deformation Parameters in Patients With Hypertrophic Cardiomyopathy
NCT04112511 ·Status: COMPLETED
-
Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
NCT02234336 ·Status: COMPLETED
-
Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy
NCT02994615 ·Status: COMPLETED
-
Exercise-induced in Secondary Mitral Regurgitation: Analysis of Echocardiographic Parameters at Rest Predicting the Onset of Significant Exercise-induced Mitral Regurgitation
NCT03978676 ·Status: COMPLETED
-
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
NCT02560467 ·Status: UNKNOWN ·Phase: NA
-
Study of Muscle Abnormalities in Patients With Specific Genetic Mutations
NCT00001871 ·Status: COMPLETED
-
Stress Cardiac MRI in Ischemic Patients
NCT04588675 ·Status: UNKNOWN
-
Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
NCT01048125 ·Status: TERMINATED ·Phase: NA